+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Specialty Drug Distribution Market: By Drug Type; By Distribution - Forecast 2017-2022

  • ID: 3339480
  • Report
  • January 2017
  • Region: Global
  • 180 pages
  • IndustryARC
Specialty Drugs are used to treat chronic diseases such as Cancer, Multiple Sclerosis and Rheumatoid Arthritis. Specialty Drugs are injectable, oral or inhaled in nature which are prescribed by the physician for special cases. Specialty Drugs is one of the fastest growing category in the Pharmaceutical market. The Specialty Drug Distribution market will see steady growth, accounting for the fact that the use of Specialty Drugs is increasing.

The Specialty Drugs Distribution Market is estimated to be $500 million in 2015. It is estimated to grow at a CAGR of 18% between 2015-2020. The driving force behind the growth is Healthcare reforms, transition in Payer dynamics and growth of Specialty Drugs. The Specialty Drug Distribution market is Oligopolistic in nature with three players dominating the market with different pricing strategies. Such a scenario creates barriers for new entrants into the market. The companies follow a pricing discount strategy which acts as a leverage for gaining market share. There are other factors such as excellent logistics, efficient supply chain and unparalleled warehousing facilities which has kept the market growing at a fast pace.

The North America region is leading the market share geographically due to better healthcare reforms, increased use of Specialty Drugs to treat chronic diseases, better distribution facilities. The European region is slowly gaining the market share in the Specialty Drug Distribution market. The vast geographical landscape in Europe serves as a major challenge in having an efficient distribution & logistics network. The highest growth is going to be witnessed in Asia Pacific region, in countries such as India, China and Australia. The reason behind the growth is improving infrastructure, innovative distribution facilities.

The Specialty Drug Distribution market is also facing challenges which restricts the market to grow steadily. The channel restriction is one of the major issues at hand. Consumers in order to get the product at a cheaper price, try to bypass the distribution channel. This leads to counterfeiting. There is also a need to collect distribution data which will help in creating restricted access channels.

Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Specialty Drug Distribution market and future opportunities are provided in the report. This report on the Global Specialty Drug Distribution Market identifies many such insights and M&A opportunities, besides providing a detailed analysis of the Specialty Drug Distribution market.

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
1. Global Specialty Drug Distribution. - Market Overview

2. Executive Summary

3. Global Specialty Drug Distribution. - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis

4. Global Specialty Drug Distribution. - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Global Specialty Drug Distribution. Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product/Market Life Cycle Analysis

6. Global Specialty Drugs– By Application
6.1. Oncology
6.2. AIDS
6.3. Multiple Sclerosis
6.4. Rheumatoid Arthritis
6.5. Hemophilia
6.6. Others

7. Global Specialty Drug Distribution. Market – By Distribution Type
7.1. Mail Delivery
7.2. Outpatient
7.3. Retail
7.4. Home Health
7.5. Clinic/ASCs
7.6. Inpatient

8. Global Specialty Drug Distribution. Market – By Distribution Channel
8.1. Full line Wholesalers
8.2. Specialty Distributors

9. Global Specialty Drug Distribution. Market – By End User
9.1. Independent Pharmacies
9.2. Large Chain Pharmacies
9.3. Hospitals
9.4. Clinics/ASCs

10. Global Specialty Drug Distribution. Market - Geographic Analysis
10.1. Introduction.
10.2. Americas
10.2.1. Canada
10.2.2. USA
10.2.3. Brazil
10.2.4. Others
10.3. Europe
10.3.1. U.K.
10.3.2. Germany
10.3.3. France
10.3.4. Spain
10.3.5. Netherlands
10.3.6. Others
10.4. APAC
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. South Korea
10.4.5. Australia
10.4.6. Others
10.5. ROW

11. Market Entropy
11.1. New Product Launches
11.2. M&As, Collaborations, JVs and Partnerships

12. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio)
12.1. Mckesson Corporation
12.2. Cardinal Health
12.3. Amerisource Bergen
12.4. Fastenal
12.5. Cintas
12.6. Grainger
12.7. MSC Industrial
12.8. Wal-Mart
12.9. Morris & Dickson
12.10. H.D. Smith
12.11. Curascript Specialty Distribution
12.12. Rochester Drug Cooperative
12.13. Smith Drug
12.14. NC Mutual Wholesale Drug
12.15. Anda Distribution
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

13. Appendix
13.1. Abbreviations
13.2. Sources
13.3. Research Methodology
13.4. Bibliography
13.5. Compilation of Expert Insights
14. Disclaimer
Note: Product cover images may vary from those shown